Detalles de la búsqueda
1.
Reproductive Decision-Making in MMR Mutation Carriers After Results Disclosure: Impact of Psychological Status in Childbearing Options.
J Genet Couns
; 25(3): 432-42, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26392361
2.
MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy.
Radiology
; 263(2): 409-18, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22438364
3.
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
JAMA
; 305(22): 2304-10, 2011 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-21642682
4.
A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors.
Cancers (Basel)
; 13(17)2021 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34503257
5.
Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer.
Cancer Chemother Pharmacol
; 60(3): 383-9, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17124595
6.
A limited sampling strategy to estimate the pharmacokinetic parameters of irinotecan and its active metabolite, SN-38, in patients with metastatic digestive cancer receiving the FOLFIRI regimen.
Oncol Rep
; 18(6): 1613-321, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17982652
7.
Pharmacokinetics and pharmacodynamics of irinotecan and its metabolites from plasma and saliva data in patients with metastatic digestive cancer receiving Folfiri regimen.
Cancer Chemother Pharmacol
; 58(3): 292-305, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16369821
8.
Safety of cisplatin combined with continuous 5-FU versus bolus 5-FU and leucovorin, in metastatic gastrointestinal cancer (FFCD 9404 randomised trial).
Anticancer Res
; 26(5B): 3877-83, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17094417
9.
Immunohistochemical staining for p16 and BRAFV600E is useful to distinguish between sporadic and hereditary (Lynch syndrome-related) microsatellite instable colorectal carcinomas.
Virchows Arch
; 469(2): 135-44, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27220764
10.
Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer risk.
Eur J Hum Genet
; 24(1): 99-105, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25873010
11.
Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen.
Cancer Chemother Pharmacol
; 52(4): 282-90, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12827293
12.
Characterization of an adaptive immune response in microsatellite-instable colorectal cancer.
Oncoimmunology
; 3: e29256, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25101223
13.
Inter-observer agreement between dermatologists and oncologists in assessing dermatological toxicities in patients with metastatic colorectal cancer treated by cetuximab-based chemotherapies: a pilot comparative study.
Eur J Cancer
; 46(18): 3169-74, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20417092
14.
[Irinotecan for the treatment of metastatic colorectal cancer]. / Modalités d'administration de l'irinotecan dans le traitement du cancer colorectal métastatique.
Bull Cancer
; 93(5): 507-15, 2006 May.
Artículo
en Francés
| MEDLINE | ID: mdl-16777630
15.
[Clinical Practice Guidelines 2004. Standards, Options and Recommendations for the management of patient with adenocarcinoma of the stomach: radiotherapy (therapeutic evaluation)]. / Recommandations pour la pratique clinique. Standards, Options et Recommandations 2004 pour la prise en charge des patients atteints d'adénocarcinomes de l'estomac, cancers du cardia, autres types histologiques exclus (évaluation des thérapeutiques).
Bull Cancer
; 92(4): 381-409, 2005 Apr.
Artículo
en Francés
| MEDLINE | ID: mdl-15888395
Resultados
1 -
15
de 15
1
Próxima >
>>